IP Library Granted Patent US 7,014,636
Granted Patent B2
US 7,014,636 · App. 10/302,104 · Granted Mar 21, 2006

Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,014,636
App. No.
10/302,104
Granted
Mar 21, 2006
Kind
B2
Abstract

An implantable osmotically driven delivery system having a dynamic, two-way valve and a self-adjusting, variable geometry fluid flow channel. As pressure within the agent delivery system increases, the fluid channel narrows, thereby restricting flow. At exceptionally high pressures, the valve can be designed to close altogether at the orifice or delivery end, or it can provide a minimal leak path so that a maximum fluid flow is never exceeded. At zero or very low pressures, the valve will close completely at the beneficial agent reservoir end, isolating the beneficial agent formulation from external fluid infiltration and thereby eliminating diffusion of external fluid into the beneficial agent formulation.

Claims (32)

1. An implantable osmotic agent delivery system, comprising:

a capsule having an impermeable outer layer;

the capsule having a beneficial agent delivery end and a fluid uptake end, the delivery end and the uptake end being located on opposite ends of the capsule; and

means for controlling fluid flow through the beneficial agent delivery end, the controlling means substantially preventing fluid flow when pressure within the capsule is below a lower predetermined pressure and above an upper predetermined pressure, and substantially allowing fluid flow when the pressure within the capsule is between the lower and upper predetermined pressures.

2. The agent delivery system according to claim 1 , wherein the fluid flow controlling means comprises:

a hollow valve body having ports provided on opposite ends thereof, a closing member and a spring being provided within the hollow valve body, wherein the spring maintains the closing member in a position to substantially cover one of the ports when the pressure within the capsule is below the lower predetermined pressure or substantially covers the other of the ports when the pressure within the capsule is above the upper predetermined pressure.

3. The agent delivery system of claim 2 , wherein the ports are configured to mate with corresponding surfaces of the closing member.

4. The agent delivery system according to claim 2 , wherein the closing member includes an upper section, a middle section and a lower section;

the upper section having a cylindrical shape;

the middle section having a conical frustum shape; and

the lower section having a cylindrical shape which is smaller in diameter than the diameter of the upper section.

5. The agent delivery system according to claim 2 , wherein the valve body comprises:

an upper fluid chamber and a lower fluid chamber;

the ports including an upper port and a lower port;

the lower port being positioned between the lower fluid chamber and a beneficial agent reservoir; and

the upper port being positioned adjacent the upper fluid chamber.

6. The agent delivery system according to claim 5 , wherein the lower fluid chamber has a lower portion and an upper portion;

the lower portion having a conical frustum shape and the upper portion having a cylindrical shape;

the upper fluid chamber having a cylindrical shape,

wherein the diameter of the upper portion of the lower fluid chamber is larger than the diameter of the upper fluid chamber;

the lower fluid chamber having a substantially flat upper surface formed between the upper portion of the lower fluid chamber and the upper fluid chamber;

wherein the closing member is housed within the lower fluid chamber;

the middle section of the closing member being configured to matingly fit with the lower portion of the lower fluid chamber and the lower section of the closing member being configured to matingly fit within and substantially seal the lower port; and

wherein the closing member has a substantially flat top surface having a diameter that is smaller than the diameter of the upper portion of the lower fluid chamber and larger than the diameter of the upper fluid chamber, such that the top surface of the closing member is capable of substantially blocking off fluid communication between the upper and lower fluid chambers when the closing member is in abutting relationship with the upper portion of the lower fluid chamber.

7. The agent delivery system according to claim 5 , wherein the spring comprises a compression spring and is positioned against a wall located between the upper port and the upper fluid chamber and applies force against the closing member to maintain the closing member against a lower section of the lower fluid chamber when the pressure is below the lower predetermined pressure.

8. The agent delivery system according to claim 5 , wherein when the pressure is above the upper predetermined pressure, the closing member substantially closes off fluid communication between the upper port and the lower fluid chamber.

9. The agent delivery system according to claim 5 , wherein when the pressure is between the lower and upper predetermined pressures, the closing member is maintained in a position substantially between the lower and upper ports.

10. The agent delivery system according to claim 1 , wherein the lower predetermined pressure is in the range of about 0.5 to about 10 pounds per square inch.

11. The agent delivery system according to claim 1 , wherein the upper predetermined pressure is in the range of about 10 to about 2000 pounds per square inch.

12. The agent delivery system according to claim 2 , wherein the spring comprises a cantilevered spring arm having two ends, one of the ends being attached to an inner surface of the hollow body; and

wherein the closing member comprises a spherical member connected to the other end of the spring arm.

13. The agent delivery system according to claim 12 , wherein the hollow valve body comprises a silicon microstructure.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: INTARCIA THERAPEUTICS, INC.; INTARCIA IRELAND LIMITED
Reel/Frame 052433/0001 →
RELEASE OF SECURITY INTEREST Recorded Jan 29, 2020
From: BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C. AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 051739/0453 →
SECURITY INTEREST Recorded Oct 23, 2019
From: INTARCIA THERAPEUTICS, INC.
To: BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C., AS COLLATERAL AGENT
Reel/Frame 050801/0267 →
SECURITY INTEREST Recorded Oct 9, 2019
From: INTARCIA THERAPEUTICS, INC.; INTARCIA IRELAND LIMITED
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050673/0020 →
RELEASE OF SECURITY INTEREST Recorded Oct 23, 2015
From: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 036942/0544 →
SECURITY AGREEMENT Recorded Nov 14, 2012
From: INTARCIA THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 029299/0678 →
RELEASE OF SECURITY INTEREST Recorded Sep 23, 2011
From: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026962/0062 →
SECURITY AGREEMENT Recorded Sep 8, 2010
From: INTARCIA THERAPEUTICS, INC.
To: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
Reel/Frame 024953/0525 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2008
From: GILBERT, SCOTT J.
To: ALZA CORPORATION
Reel/Frame 021069/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2007
From: GILBERT, SCOTT JAY
To: ALZA CORPORATION
Reel/Frame 020141/0354 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2007
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 020035/0441 →